CSERMELY, ALESSANDRO
 Distribuzione geografica
Continente #
NA - Nord America 265
EU - Europa 167
AS - Asia 47
Totale 479
Nazione #
US - Stati Uniti d'America 262
IE - Irlanda 38
IT - Italia 38
CN - Cina 33
SE - Svezia 32
FR - Francia 26
FI - Finlandia 15
KR - Corea 12
DE - Germania 11
CA - Canada 3
BE - Belgio 2
ES - Italia 2
LV - Lettonia 2
AZ - Azerbaigian 1
GB - Regno Unito 1
IL - Israele 1
Totale 479
Città #
Chandler 87
Dublin 36
Ashburn 33
New York 19
Beijing 14
Helsinki 12
Seoul 12
Verona 9
Lawrence 8
Princeton 8
Redmond 8
Seattle 7
Washington 7
Wilmington 7
Bologna 5
Sindelfingen 5
Bussolengo 3
Cagliari 3
Dongguan 3
Fermo 3
Lappeenranta 3
Los Angeles 3
Stoney Creek 3
Brussels 2
Chions 2
Falkenstein 2
Jacksonville 2
Lanzhou 2
Marigliano 2
Rome 2
San Giovanni Lupatoto 2
Zaragoza 2
Ann Arbor 1
Baku 1
Cambridge 1
Changsha 1
Columbus 1
Esslingen am Neckar 1
Mehlingen 1
Paularo 1
Riga 1
Shenyang 1
Southend 1
Taiyuan 1
Taizhou 1
Tappahannock 1
Tel Aviv 1
Totale 331
Nome #
Growing up with type 1 diabetes mellitus: Data from the Verona Diabetes Transition Project 53
Non-alcoholic fatty liver disease and risk of fatal and non-fatal cardiovascular events: an updated systematic review and meta-analysis 48
Glucagon-Like Peptide-1 Receptor Agonists for Treatment of Nonalcoholic Fatty Liver Disease and Nonalcoholic Steatohepatitis: An Updated Meta-Analysis of Randomized Controlled Trials 43
Association between higher serum uric acid levels and plasma N-terminal pro-B-type natriuretic peptide concentrations in patients with coronary artery disease and without overt heart failure 43
Role of monogenic diabetes genes on beta cell function in Italian patients with newly diagnosed type 2 diabetes. The Verona Newly Diagnosed Type 2 Diabetes Study (VNDS) 13 42
Association between Higher Circulating Leucine-Rich α-2 Glycoprotein 1 Concentrations and Specific Plasma Ceramides in Postmenopausal Women with Type 2 Diabetes 39
Sodium-Glucose Cotransporter-2 Inhibitors for Treatment of Nonalcoholic Fatty Liver Disease: A Meta-Analysis of Randomized Controlled Trials 35
Non-alcoholic fatty liver disease and risk of incident chronic kidney disease: an updated meta-analysis 35
Non-alcoholic fatty liver disease and increased risk of incident extrahepatic cancers: a meta-analysis of observational cohort studies 34
Non-alcoholic fatty liver disease and risk of new-onset heart failure: an updated meta-analysis of about 11 million individuals 22
Association between lower plasma adiponectin levels and higher liver stiffness in type 2 diabetic individuals with nonalcoholic fatty liver disease: an observational cross-sectional study 22
Association Between Metabolic Dysfunction-Associated Fatty Liver Disease and Supraventricular and Ventricular Tachyarrhythmias in Patients with Type 2 Diabetes 20
Association between PNPLA3 rs738409 variant and 5-year estimated glomerular filtration rate decline in post-menopausal women with type 2 diabetes: A panel-data analysis 20
Long-Term Adverse Effect of Liver Stiffness on Glycaemic Control in Type 2 Diabetic Patients with Nonalcoholic Fatty Liver Disease: A Pilot Study 15
Associations between higher plasma ferritin and hepcidin levels with liver stiffness in patients with type 2 diabetes: An exploratory study 12
Association between different modalities of insulin administration and metabolic dysfunction-associated fatty liver disease in adults with type 1 diabetes mellitus 9
Comparative effects of non-alcoholic fatty liver disease and metabolic dysfunction-associated fatty liver disease on risk of incident cardiovascular events: a meta-analysis of about 13 million individuals 9
Higher circulating levels of non-esterified fatty acids are associated with faster kidney function decline in post-menopausal women with type 2 diabetes: a pilot prospective study 1
Totale 502
Categoria #
all - tutte 2.824
article - articoli 2.824
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 5.648


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20218 0 0 0 0 0 0 2 5 0 0 1 0
2021/202257 0 5 0 7 0 8 5 9 5 4 3 11
2022/2023257 9 26 19 50 18 60 10 12 22 1 23 7
2023/2024180 7 7 33 20 23 50 14 8 0 17 1 0
Totale 502